Oxford Immunotec is a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions. The company's T-SPOT.TB test is used for diagnosing tuberculosis infection, and its T-SPOT.CMV test is used for diagnosing cytomegalovirus infection. Oxford Immunotec was founded in 2002 and is headquartered in Abingdon, United Kingdom.